ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results...
Allergan plc announced that it has received an Imported Drugs License (IDL) from the Chinese FDA to market Ozurdex® (dexamethasone...
Enterome SA, a pioneer of innovative therapies for microbiome-related diseases, has announced the successful completion of the first phase 1...
Servier and GeNeuro announced post hoc analyses of 6-month data from the CHANGE-MS Phase 2b study of GNbAC1 for the...
Biogen (NASDAQ: BIIB) and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best Biotechnology Product for...
Eagle Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s...
AbbVie , a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.announced that the U.S. FDA...
AstraZeneca and Merck , known as MSD outside the U.S. and Canada, announced that they have submitted a NDA to...
Roche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in...
Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has received final approval from US FDA for...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
